221 related articles for article (PubMed ID: 37246067)
21. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
[TBL] [Abstract][Full Text] [Related]
22. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
[TBL] [Abstract][Full Text] [Related]
23. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.
Block JP; Boehmer TK; Forrest CB; Carton TW; Lee GM; Ajani UA; Christakis DA; Cowell LG; Draper C; Ghildayal N; Harris AM; Kappelman MD; Ko JY; Mayer KH; Nagavedu K; Oster ME; Paranjape A; Puro J; Ritchey MD; Shay DK; Thacker D; Gundlapalli AV
MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(14):517-523. PubMed ID: 35389977
[TBL] [Abstract][Full Text] [Related]
24. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.
Montgomery J; Ryan M; Engler R; Hoffman D; McClenathan B; Collins L; Loran D; Hrncir D; Herring K; Platzer M; Adams N; Sanou A; Cooper LT
JAMA Cardiol; 2021 Oct; 6(10):1202-1206. PubMed ID: 34185045
[TBL] [Abstract][Full Text] [Related]
25. Acute myocarditis following a third dose of COVID-19 mRNA vaccination in adults.
Simone A; Herald J; Chen A; Nayak R; Shen YA; Lee MS
Int J Cardiol; 2022 Oct; 365():41-43. PubMed ID: 35870635
[TBL] [Abstract][Full Text] [Related]
26. COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis.
Chou OHI; Mui J; Chung CT; Radford D; Ranjithkumar S; Evbayekha E; Nam R; Pay L; Satti DI; Garcia-Zamora S; Bazoukis G; Çinier G; Lee S; Vassiliou VS; Liu T; Tse G; Wong ICK; ; Chou OHI; Liu T; Tse G
Clin Res Cardiol; 2022 Oct; 111(10):1161-1173. PubMed ID: 35906423
[TBL] [Abstract][Full Text] [Related]
27. Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines.
Le Vu S; Bertrand M; Jabagi MJ; Botton J; Drouin J; Baricault B; Weill A; Dray-Spira R; Zureik M
Nat Commun; 2022 Jun; 13(1):3633. PubMed ID: 35752614
[TBL] [Abstract][Full Text] [Related]
28. Benefit-risk assessment of COVID-19 vaccine, mRNA (Comirnaty) for age 16-29 years.
Funk PR; Yogurtcu ON; Forshee RA; Anderson SA; Marks PW; Yang H
Vaccine; 2022 Apr; 40(19):2781-2789. PubMed ID: 35370016
[TBL] [Abstract][Full Text] [Related]
29. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel.
Halsell JS; Riddle JR; Atwood JE; Gardner P; Shope R; Poland GA; Gray GC; Ostroff S; Eckart RE; Hospenthal DR; Gibson RL; Grabenstein JD; Arness MK; Tornberg DN;
JAMA; 2003 Jun; 289(24):3283-9. PubMed ID: 12824210
[TBL] [Abstract][Full Text] [Related]
30. Vaccination-Associated Myocarditis and Myocardial Injury.
Altman NL; Berning AA; Mann SC; Quaife RA; Gill EA; Auerbach SR; Campbell TB; Bristow MR
Circ Res; 2023 May; 132(10):1338-1357. PubMed ID: 37167355
[TBL] [Abstract][Full Text] [Related]
31. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.
Fazlollahi A; Zahmatyar M; Noori M; Nejadghaderi SA; Sullman MJM; Shekarriz-Foumani R; Kolahi AA; Singh K; Safiri S
Rev Med Virol; 2022 Jul; 32(4):e2318. PubMed ID: 34921468
[TBL] [Abstract][Full Text] [Related]
32. Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting.
Yap J; Tham MY; Poh J; Toh D; Chan CL; Lim TW; Lim SL; Chia YW; Lim YT; Choo J; Ding ZP; Foo LL; Kuo S; Lau YH; Lee A; Yeo KK
Ann Acad Med Singap; 2022 Feb; 51(2):96-100. PubMed ID: 35224605
[TBL] [Abstract][Full Text] [Related]
33. Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system.
Chen C; Fu F; Ding L; Fang J; Xiao J
Front Immunol; 2022; 13():938322. PubMed ID: 36172346
[TBL] [Abstract][Full Text] [Related]
34. Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis.
Ahmed SK; Mohamed MG; Essa RA; Ahmed Rashad EA; Ibrahim PK; Khdir AA; Wsu ZH
Diabetes Metab Syndr; 2022 Jun; 16(6):102513. PubMed ID: 35660931
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 review shows that benefits of vaccinating children and adolescents appear to outweigh risks of post-vaccination myopericarditis.
Morello R; Pepe M; Martino L; Lazzareschi I; Chiaretti A; Gatto A; Curatola A
Acta Paediatr; 2022 Oct; 111(10):1846-1852. PubMed ID: 35735066
[TBL] [Abstract][Full Text] [Related]
36. Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States.
Hatziantoniou S; Anastassopoulou C; Lazaros G; Vasileiou K; Tsioufis C; Tsakris A
Expert Rev Vaccines; 2022 Nov; 21(11):1691-1696. PubMed ID: 35815358
[TBL] [Abstract][Full Text] [Related]
37. Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
Klein NP; Lewis N; Goddard K; Fireman B; Zerbo O; Hanson KE; Donahue JG; Kharbanda EO; Naleway A; Nelson JC; Xu S; Yih WK; Glanz JM; Williams JTB; Hambidge SJ; Lewin BJ; Shimabukuro TT; DeStefano F; Weintraub ES
JAMA; 2021 Oct; 326(14):1390-1399. PubMed ID: 34477808
[TBL] [Abstract][Full Text] [Related]
38. Temporal relationship of myocarditis and pericarditis following COVID-19 vaccination: A pragmatic approach.
Anastassopoulou C; Hatziantoniou S; Vlachopoulos C; Spanakis N; Tsioufis C; Tsakris A; Lazaros G
Int J Cardiol; 2022 Jul; 358():136-139. PubMed ID: 35436559
[TBL] [Abstract][Full Text] [Related]
39. Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.
Li X; Gao L; Tong X; Chan VKY; Chui CSL; Lai FTT; Wong CKH; Wan EYF; Chan EWY; Lau KK; Lau CS; Wong ICK
J Autoimmun; 2022 Jun; 130():102830. PubMed ID: 35461018
[TBL] [Abstract][Full Text] [Related]
40. A population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients.
Naveed Z; Li J; Naus M; Velásquez García HA; Wilton J; Janjua NZ;
Int J Infect Dis; 2023 Jun; 131():75-78. PubMed ID: 36967038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
